JournalsHub
.online
Find My Journal
GH

Gabriel N. Hortobágyi

The University of Texas MD Anderson Cancer Center US

ORCID 0000-0002-4873-4412
1,905
Publications
139,709
Citations
187
H-Index
934
i10-Index
9.09
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer OA
Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, Fabrice André, Attila Tordai +8 more
Journal of Clinical Oncology 2008
2,877
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer OA
José Baselga, Mario Campone, Martine Piccart, Howard A. Burris, Hope S. Rugo +16 more
New England Journal of Medicine 2011
2,808
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer OA
Gabriel N. Hortobágyi, Salomon M. Stemmer, Howard A. Burris, Yoon Sim Yap, Gabe S. Sonke +32 more
New England Journal of Medicine 2016
1,960
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy OA
Roman Rouzier, Charles M. Perou, W. Fraser Symmans, Nuhad K. Ibrahim, Massimo Cristofanilli +11 more
Clinical Cancer Research 2005
1,881
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients OA
Yoichi Nagata, Keng‐Hsueh Lan, Xiaoyan Zhou, Ming Tan, Francisco J. Esteva +8 more
Cancer Cell 2004
1,856

Publications

1,904 total

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer PDF

Rashmi K. Murthy, Sherene Loi, Alicia Okines, Elisavet Paplomata, Erika Hamilton et al. - New England Journal of Medicine, 2019
Cited by 1,282 OpenAlex

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer PDF

Gabriel N. Hortobágyi, Salomon M. Stemmer, Howard A. Burris, Yoon Sim Yap, Gabe S. Sonke et al. - New England Journal of Medicine, 2016
Cited by 1,960 OpenAlex

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity PDF

Chia‐Wei Li, Seung-Oe Lim, Weiya Xia, Heng‐Huan Lee, Li-Chuan Chan et al. - Nature Communications, 2016
Cited by 1,089 OpenAlex

ESR1 ligand-binding domain mutations in hormone-resistant breast cancer PDF

Weiyi Toy, Yang Shen, Helen Won, Bradley Green, Rita A. Sakr et al. - Nature Genetics, 2013
Cited by 1,238 OpenAlex

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer PDF

José Baselga, Mario Campone, Martine Piccart, Howard A. Burris, Hope S. Rugo et al. - New England Journal of Medicine, 2011
Cited by 2,808 OpenAlex

Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation PDF

Benjamin D. Smith, Grace L. Smith, Arti Hurria, Gabriel N. Hortobágyi, Thomas A. Buchholz - Journal of Clinical Oncology, 2009
Cited by 1,719 OpenAlex

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial PDF

Kathy S. Albain, William E. Barlow, Steven Shak, Gabriel N. Hortobágyi, Robert B. Livingston et al. - The Lancet Oncology, 2009
Cited by 1,391 OpenAlex

The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine PDF

Jeffrey S. Ross, Elzbieta Slodkowska, W. Fraser Symmans, Lajos Pusztai, Peter M. Ravdin et al. - The Oncologist, 2009
Cited by 1,148 OpenAlex

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer PDF

Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, Fabrice André, Attila Tordai et al. - Journal of Clinical Oncology, 2008
Cited by 2,877 OpenAlex

Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy PDF

W. Fraser Symmans, Florentia Peintinger, Christos Hatzis, Radhika Rajan, Henry M. Kuerer et al. - Journal of Clinical Oncology, 2007
Cited by 1,631 OpenAlex

Research Topics

Breast Cancer Treatment Studies (609) Cancer Treatment and Pharmacology (467) HER2/EGFR in Cancer Research (432) Advanced Breast Cancer Therapies (262) Cancer Genomics and Diagnostics (193)

Frequent Co-Authors

LA
Lajos Pusztai
5 joint publications
W.
W. Fraser Symmans
4 joint publications
MA
Massimo Cristofanilli
4 joint publications
TH
Thomas Bachelot
3 joint publications
ER
Eric P. Winer
3 joint publications
AY
Ayşegül A. Şahin
3 joint publications

Affiliations

Université Paris-Sud
FR 2008 - 2008
Boston University
US 2023 - 2023
Northwestern University
US 2007 - 2007
Hiroshima University
JP 2006 - 2005
Goethe University Frankfurt
DE 2006 - 2006

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now